Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
CA 2666005 C · Owner: Ramalingam, Kondareddiar · Inventors: Song, Bo; Sato, Aaron K.; Pillai, Radhakrishna
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides binding polypeptides for KDR or VEGF/KDR complex, which have a variety of uses wherever treating detecting, isolating or localizing angiogenesis is advantageous. Particularly disclosed are , synthetic, isolated polypeptides capable of binding KDR or VEGF/KDR complex with , high affinity (e.g. having a K D<1 µM). The polypeptides of the present invention , which have the ability to bind to KDR or VEGF/KDR may be conjugated to a microvesicle to provide an ultrasound contrast agent.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 3, 2003 and granted January 19, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 3, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 3, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.